Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Giampiero, Romano"'
Autor:
Pietrina Romano, Emanuela Civino, Nicola Di Renzo, Elena Pitotti, Michele Maffia, Marcello Salvatore Lenucci, Giammarco Surico, Cosimo Neglia, Daniele Vergara, Alessandro Distante, Prisco Piscitelli, Giampiero Romano, Andrea Ragusa
Publikováno v:
Metabolites
Metabolites, Vol 11, Iss 566, p 566 (2021)
Volume 11
Issue 9
Metabolites, Vol 11, Iss 566, p 566 (2021)
Volume 11
Issue 9
Glycans play a fundamental role in several biological processes, such as cell–cell adhesion, signaling, and recognition. Similarly, abnormal glycosylation is involved in many pathological processes, among which include tumor growth and progression.
Autor:
Cesare Gridelli, Filippo de Marinis, Vito Barbieri, Maria Rita Migliorino, Massimo Barberis, Fabiana Vitiello, Giampiero Romano, Stefano Gasparini, Alfonso Marchianò, Francesca Spinnato
Publikováno v:
Expert Review of Respiratory Medicine. 13:217-228
In the era of personalized cancer therapy, the sampling of adequate tumor tissue for histologic diagnosis and genomic profiling is crucial, not only at the initial diagnosis but also in the event of resistant and recurrent disease when sequential bio
Autor:
Benjamin Besse, Rosario Garcia Campelo, Manuel Cobo-Dols, Elisabeth Anne Quoix, Anne Madroszyk, Enriqueta Felip, Federico Cappuzzo, Fabrice Denis, Werner Hilgers, Giampiero Romano, Didier Debieuvre, Domenico Galetta, Editta Baldini, Santiago Viteri Ramirez, Minh Duc Phan, Wolfgang Schuette, Alona Zer, Berangere Vasseur, Rafal Dziadziuszko, Giuseppe Giaccone
Publikováno v:
Journal of Clinical Oncology. 40:9094-9094
9094 Background: OSE2101 (Tedopi) is an anticancer vaccine increasing overall survival (OS) versus Standard of Care (SoC docetaxel or pemetrexed) in HLA-A2+ NSCLC patients with secondary resistance after sequential Chemo (CT)-IO (ESMO 2021 #47LBA). H
Autor:
Giovanni Luca Ceresoli, Barbara Melotti, Diego Signorelli, Francesco Verderame, Alice Lunghi, Vieri Scotti, Enrico Cortesi, Giacomo Cartenì, Daniele Turci, Gianpiero Fasola, Enrico Ricevuto, Paolo Marchetti, Carmelo Tibaldi, Alfonso Illiano, Luisa Fioretto, Diana Giannarelli, Editta Baldini, Antonio Frassoldati, Carmine Pinto, Biagio Ricciuti, Giampiero Romano, Valeria Stati
Objectives The incidence of any and of severe-grade immune-related adverse events (irAEs) with second-line nivolumab monotherapy is 31–65 % and 2–5 % respectively. While potentially serious and even fatal, in the absence of an appropriate therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28894fc3abc7f2350fa495f0a094b05
http://hdl.handle.net/11392/2418755
http://hdl.handle.net/11392/2418755
Autor:
Giacomo Cartenì, Filippo de Marinis, Flavia Longo, Gianpiero Fasola, Domenico Galetta, Alberto Caprioli, Dario Giuffrida, Alberto Zaniboni, Valentina Acciai, Oscar Alabiso, Maria Rita Migliorino, Antonio Santo, Antonio Pazzola, Diego Cortinovis, Giampiero Romano, Sabrina Vari
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 143:783-791
Non-small cell lung cancer (NSCLC) is a condition with significant clinical burden for patients and relevant economic impact. Limited evidence exists on the management costs of NSCLC patients, especially in the late phases of the disease. The main ob
Autor:
Antonio Rossi, Umberto Malapelle, Lorenza Landi, Giampiero Romano, Michele Montrone, Tindara Franchina, Alessandro Morabito, Elisa Roca, Paola Mazzanti, Alessandra Bulotta, Roberto Bianco, Sara Pilotto, Lucio Buffoni, Barbara Melotti, Vito Barbieri, C.Y. Finocchiaro, Annamaria Carta, Lorenzo Piccolo, Gianfranco Mancuso, Vincenzo Minotti, Ivano Boscardini, Raffaele Costanzo, Romano Danesi, Alessandro Del Conte, Alessandra Rota, Gloria Borra, Giuseppa Savio, Vanesa Gregorc, Olga Martelli, Luciana Irtelli, Marcello Tiseo, Antonio Cusmai, Diego Cortinovis, Maria Rita Migliorino, Marina Gilli, Anna Cecilia Bettini, Francesco Malorgio, Ettore D'Argento
Publikováno v:
Translational Cancer Research
Background: In the field of oncological assistance, nowadays we have to deal with a complex scenario where patients got used to obtain a huge amount of information through internet or social media and to apply them in performing their health-related
Autor:
Editta, Baldini, Alice, Lunghi, i Enrico Cortesi, Daniele, Turci, Maria Chiara Garassino, Stati, Valeria, Andrea, Ardizzoni, Biagio, Ricciuti, Antonio, Frassoldati, Giampiero, Romano, Alfonso, Illiano, Francesco, Verderame, Gianpiero, Fasola, Marchetti, Paolo, Carmine, Pinto, Giacomo, Cartenì, Vieri, Scotti, Carmelo, Tibaldi, Luisa, Fioretto, Diana, Giannarelli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::fc6959cb1ce9aab2f958eb33252f1fef
http://hdl.handle.net/11573/1349324
http://hdl.handle.net/11573/1349324
Autor:
Francesco Verderame, Alice Lunghi, Enrico Cortesi, Editta Baldini, Marina Chiara Garassino, Daniele Turci, Valeria Stati, Diana Giannarelli, Giacomo Cartenì, Gianpiero Fasola, Carmine Pinto, Vieri Scotti, Luisa Fioretto, Piero Marchetti, Biagio Ricciuti, Giampiero Romano, A. Ardizzoni, Alfonso Illiano, Carmelo Tibaldi, Antonio Frassoldati
Publikováno v:
Annals of Oncology. 29:x18-x19
Autor:
Benjamin Besse, Philippe Masson, Domenico Galetta, Teresa Moran, Christos Chouaid, Werner Hilgers, Bérangère Vasseur, Fabrice Denis, F.R. Ferrand, Giampiero Romano, Rafal Dziadziuszko, Giuseppe Giaccone, Didier Debieuvre, Jordi Remon, François Roger Vanel, Nir Peled, Enriqueta Felip, Anne Madroszyk, Federico Cappuzzo, Manuel Cobo
Publikováno v:
Journal of Clinical Oncology. 37:TPS9121-TPS9121
TPS9121 Background: New treatment strategies are needed for advanced NSCLC patients who progress on treatment with immune checkpoint inhibitors (ICI). Tedopi (OSE2101) is a neoepitope vaccine restricted to HLA-A2 positive patients (45%) targeting fiv
Autor:
Olivier Molinier, Julien Mazieres, Enriqueta Felip, Istvan Albert, Sylvestre Le Moulec, Christos Chouaid, Benjamin Besse, Damien Pouessel, Rafal Dziadziuszko, Nicolas Girard, Romain Corre, Giampiero Romano, Eric Pichon, Giuseppe Giaccone, Jordi Remon
Publikováno v:
Journal of Thoracic Oncology. 12:S1085-S1086